Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial with Median 15 Years Follow-up

BACKGROUND: Two large-scale prostate cancer screening trials with prostate-specific antigen (PSA) have given conflicting results in terms of the efficacy of such screening. One of those trials, the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, previously reported outcomes thr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Pinsky, Paul F., Prorok, Philip C., Yu, Kelly, Kramer, Barnett S., Black, Amanda, Gohagan, John, Crawford, E. David, Grubb, Robert, Andriole, Gerald
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725951/
https://ncbi.nlm.nih.gov/pubmed/27911486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30474
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares